ReviewFrontiers in pharmacology2023
Therapeutic potential of the chemical composition of
Review in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- Merits of bioactivity and products ofFrontiers in plant science · 2026Pooled it
- Research Progress on the Alkaloids ofCurrent issues in molecular biology · 2026Review
- First Divergent Total Synthesis of (±)-Nobilin D and Structurally Related Bibenzyl Natural Products.ACS omega · 2026Article
- Hepatoprotective action ofFrontiers in pharmacology · 2026Article
- Evaluating the accumulation of organic acids and fatty acids under different environmental stresses in Dendrobium nobile.BMC plant biology · 2025Article
- Integrated Omics RevealPharmaceuticals (Basel, Switzerland) · 2025Article
- Fused Nitrogen Bridgehead N,O-Acetals as Versatile Scaffolds: Synthetic Strategies, Mechanism and Applications.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Review
- Light intensity is a crucial factor that regulates growth, physiological traits, antioxidant defense, and metabolite acquisition inPhysiology and molecular biology of plants : an international journal of functional plant biology · 2025Article
- Study on Differences in Structure and Anti-Inflammatory Activity of Polysaccharides in Five Species of Dendrobium.Polymers · 2025Article
- The Double-Edge Sword of Natural Phenanthrenes in the Landscape of Tumorigenesis.Molecules (Basel, Switzerland) · 2025Review
- Article
- The multi-chromosomal structure of mitogenomes provided new insights into the accurate authentication of medicinal Dendrobium species.BMC plant biology · 2025Article
- Integrated transcriptomic and metabolomic analyses reveal critical gene regulatory network in response to drought stress in Dendrobium nobile Lindl.BMC plant biology · 2025Article
- Recent advances in polysaccharides derived from theFrontiers in pharmacology · 2025Review
- Article
- Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review.Frontiers in pharmacology · 2025Review
- Network pharmacology and anticancer mechanism study of Dendrobium nobile dendrobine in the treatment of colorectal cancer.Discover oncology · 2024Article
- Effect ofWorld journal of gastroenterology · 2024Article
- Enteric Delayed-Release Granules Loading Dendrobine Ameliorates Hyperlipidemia in Mice by Regulating Intestinal Flora Composition.Pharmaceutics · 2024Article
- Research progress on the regulatory and pharmacological mechanism of chemical components of Dendrobium.Heliyon · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.